December 20, 2018
Kalytera Provides Update on Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD
December 19, 2018
Kalytera Announces Private Placement of Common Shares and Common Share Purchase Warrants
November 30, 2018
Kalytera Reports Third Quarter 2018 Financial Results
November 12, 2018
Kalytera Announces Next Share Issuance for Services under Payments Agreement with Salzman Group
September 27, 2018
Kalytera Announces Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
September 24, 2018
Kalytera Announces Grant of Stock Options to Directors and Employees
September 20, 2018
Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD
August 30, 2018
Kalytera Reports Second Quarter 2018 Financial Results
August 17, 2018
Kalytera Announces Further Payments in Shares under Payments Agreements with Salzman Group
August 16, 2018
Kalytera Announces Exercise of Over-Allotment Option
August 8, 2018
Kalytera Announces Closing of Public Offering
August 2, 2018
Kalytera Completes Pre-IND Meeting with FDA
July 20, 2018
Kalytera and Former Shareholders of Talent Biotechs Agree to Deferment of Milestone Payments
July 19, 2018
Kalytera to Enter Medical Cannabis Market With Focus on Treatment of Psoriasis and Menstrual Cramps
July 5, 2018
Kalytera Announces Pre-IND Meeting Date with FDA
June 4, 2018
Kalytera Announces Next Monthly Payment in Shares under Services Agreement with Salzman Group
May 2, 2018
Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease
May 1, 2018
Kalytera Reports 2017 Financial Results
April 26, 2018
Kalytera Issues CEO Letter to Shareholders
March 22, 2018
Kalytera Announces Next Issuance of Shares under Services Agreement with Salzman Group
March 20, 2018
Kalytera Initiates Program to Develop a Novel Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
March 14, 2018
Kalytera Announces Grant of Stock Options to Chief Scientific Officer and Chief Medical Officer
February 23, 2018
Kalytera Announces Further Issuance of Shares under Services Agreement with Salzman Group
January 31, 2018
Kalytera Announces Grant of Stock Options
January 26, 2018
Kalytera Announces Issuance of Shares under Services Agreement with The Salzman Group of Israel
January 11, 2018